Micrologix Biotech Inc.
Records under this name other than patents Micrologix Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Micrologix Biotech Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,138,144 | Antimicrobial cationic peptides and formulations thereof Formerly held Term ended Term ended Oct 9, 2023 · From the USPTO record | Term ended | Term ended Oct 9, 2023 | From the USPTO record |
| US 8,933,029 | Antimicrobial and anti-inflammatory peptides Formerly held Lapsed on the fee record Ended Jan 13, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 13, 2023 | From the USPTO record |
| US 6,835,536 | Antimicrobial cationic peptides and formulations thereof Formerly held Term ended Term ended Nov 19, 2022 · From the USPTO record | Term ended | Term ended Nov 19, 2022 | From the USPTO record |
| US 6,881,831 | Nucleic acid-based compounds and methods of use thereof Formerly held Term ended Term ended May 15, 2022 · From the USPTO record | Term ended | Term ended May 15, 2022 | From the USPTO record |
| US 6,620,796 | Combinatorial library synthesis and pharmaceutically active compounds produced thereby Formerly held Term ended Term ended Nov 8, 2020 · From the USPTO record | Term ended | Term ended Nov 8, 2020 | From the USPTO record |
| US 6,180,604 | Compositions and methods for treating infections using analogues of indolicidin Formerly held Term ended Term ended Aug 20, 2017 · From the USPTO record | Term ended | Term ended Aug 20, 2017 | From the USPTO record |
| US 6,503,881 | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics Formerly held Term ended Ended no later than Aug 20, 2017 · From the USPTO record | Term ended | Ended no later than Aug 20, 2017 | From the USPTO record |
| US 7,390,787 | Compositions and methods for treating infections using analogues of indolicidin Formerly held Term ended Ended no later than Aug 20, 2017 · From the USPTO record | Term ended | Ended no later than Aug 20, 2017 | From the USPTO record |
| US 6,737,403 | Derivatives of laspartomycin and preparation and use thereof Formerly held Lapsed on the fee record Ended May 18, 2016 · From the USPTO record | Lapsed on the fee record | Ended May 18, 2016 | From the USPTO record |
| US 7,309,759 | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics Formerly held Lapsed on the fee record Ended Dec 18, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 18, 2015 | From the USPTO record |